Publication | Closed Access

New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology

InfertilityHormonal ContraceptiveFertilityMedicineReproductive HealthProgestin-primed Ovarian StimulationGynecologyHormonal Male ContraceptionNew TrialReproductive HormonePublic HealthEndocrinologyPharmacologyOvarian HormoneWomen's HealthOvarian CancerAssisted Reproductive Technology